HTRA1 and ovarian cancer: Hence, together with our data obtained in the validation set, these data may support previous results in gastric and ovarian cancer [18], [19] which have linked HTRA1 proficiency to better therapeutic responsiveness indicating that HTRA1 is a predictive marker.